Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
Intermittent preventive treatment (IPT) is used to reduce malaria morbidity and mortality, especially in vulnerable groups such as children and pregnant women. IPT with the fixed dose combination of piperaquine (PQ) and dihydroartemisinin (DHA) is being evaluated as a potential mass treatment to con...
Үндсэн зохиолчид: | Permala, J, Tarning, J, Nosten, F, White, N, Karlsson, M, Bergstrand, M |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
American Society for Microbiology
2017
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
-н: Chotsiri, P, зэрэг
Хэвлэсэн: (2019) -
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
-н: Palang Chotsiri, зэрэг
Хэвлэсэн: (2019-01-01) -
Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
-н: Bergstrand, M, зэрэг
Хэвлэсэн: (2014) -
Efficacy and safety of dihydroartemisinin-piperaquine.
-н: Myint, H, зэрэг
Хэвлэсэн: (2007) -
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
-н: Lwin, K, зэрэг
Хэвлэсэн: (2012)